Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 6, 2000, Pages 1468-1476

  Fortunato, Stephen J ^a,b   Menon, Ramkumar ^a,b,c   Bryant, Carrie ^d   Lombardi, Salvatore J ^a  

^a Maternal Fetal Group   (United States)

^b Perinatal Research Center   (United States)

^c Aquinas College Nashville   (United States)

^d Franklin Road Academy ^*  (United States)

Author keywords

Amnion chorion; Apoptosis; Bax; Ligation mediated polymerase chain reaction; Matrix metalloproteinase 2; p53; Premature rupture of membranes

Indexed keywords

DNA FRAGMENT; GELATINASE A; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; CONFERENCE PAPER; FEMALE; FETUS MEMBRANE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE INDUCTION; HUMAN; HUMAN TISSUE; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033946384     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107330     Document Type: Article

References (24)

1. 1. Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP, et al. Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol 1995;173:1506-12.
2. 2. Bryant-Greenwood GD, Yamamoto SY. Control of peripartal collagenolysis in the human chorion-decidua. Am J Obstet Gynecol 1995;172:63-70.
3. 3. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998; 179:1248-53.
4. 4. Fortunato SJ, Menon R, Lombardi SJ. Stromelysins in placental membranes and its elevation in amniotic fluid during premature rupture of membrane. Obstet Gynecol 1999;94:435-40.
5. 5. Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membranes). Am J Obstet Gynecol 1997;177:734-41.
6. 6. Athayde N, Romero R, Gomez R, Maymon E, Pacora P, Mazor M, et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matern Fetal Med 1999;8:213-9.
7. 7. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L, Iwata K, Strauss JF 3d. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-6.
8. 8. Fortunato SJ, Menon R, Lombardi SJ. Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: A possible infections pathway to rupture. Obstet Gynecol 2000;95:240-4.
9. 9. Anita E, Murphy AN, Stetler-Stevenson WG. 72-kDa gelatinase (gelatinase A): structure, activation regulation, and substrate specificity. In: Parks WC, Mecham RP, editors. Matrix metalloproteinases. San Diego: Academic Press; 1998. p. 85-113.
10. 10. Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999;27:362-8.
11. 11. Tryggvason K, Huhtala P, Tuuttila A, Chow L, Keski-Oja J, Lohi J. Structure and expression of type IV collagenase. Cell Differ Dev 1990;32:307-12.
12. 12. Bian J, Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 1997;17:6330-8.
13. 13. Lei H, Furth EE, Kalluri R, Chiou T, Tilly KI, Tilly JL, et al. A program of cell death and extracellular matrix degradation is activaled in the amnion before the onset of labor. J Clin Invest 1996;98:1971-8.
14. 14. Pietenpol JA, Tokino T, Thiagalingam S, el-Deiry WS, Kinzler KW, Vogelstein B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci U S A 1994;91:1998-2002.
15. 15. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992;1:45-9.
16. 16. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993;1155:181-205.
17. 17. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996; 10:1054-72.
18. 18. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-805.
19. 19. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
20. 20. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
21. 21. De Clerck YA, Darville M, Eeckhout Y, Rousseau GG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 1994;139: 185-91.
22. 22. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, et al. The TIMP2 membrane type I metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A: a kinetic study. J Biol Chem 1998; 273:871-80.
23. 23. Fridman R, Toth M, Pena D, Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 1995;55:2548-55.
24. 24. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 1995;376:345-55.